Taiyen Biotech Co Ltd (1737) — Long-term Investment Intensity
Taiyen Biotech Co Ltd (1737) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of NT$43.53 Million represent 0.6% of total assets of NT$7.60 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Taiyen Biotech Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Taiyen Biotech Co Ltd Long-term Investment Intensity (2013–2019)
This chart shows how Taiyen Biotech Co Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of NT$43.53 Million against total assets of NT$7.60 Billion TWD. Explore how well can Taiyen Biotech Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Taiyen Biotech Co Ltd (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Taiyen Biotech Co Ltd from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 1737 market cap.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.6% | NT$43.53 Million | NT$7.60 Billion | ▲ +0.4 pp |
| 2018 | 0.2% | NT$11.69 Million | NT$7.33 Billion | ▼ -0.4 pp |
| 2017 | 0.5% | NT$37.91 Million | NT$7.25 Billion | ▼ -0.4 pp |
| 2016 | 1.0% | NT$67.24 Million | NT$7.05 Billion | ▼ -3.6 pp |
| 2015 | 4.5% | NT$310.94 Million | NT$6.85 Billion | ▲ +0.3 pp |
| 2014 | 4.2% | NT$283.62 Million | NT$6.74 Billion | ▲ +0.3 pp |
| 2013 | 3.9% | NT$243.54 Million | NT$6.17 Billion | — |